Compounded semaglutide vs brand name: what is the difference and is it safe?

The primary difference between compounded semaglutide and brand-name semaglutide is regulation: brand-name versions are FDA-approved and rigorously tested for safety and consistency, while compounded versions are not FDA-approved and are prepared by state-licensed pharmacies with variable quality controls [1][2][4].

Regarding safety, compounded semaglutide is not guaranteed to be safe or effective due to the lack of formal regulatory oversight, potential for impurities, incorrect dosing, and the use of chemically different salt derivatives (like semaglutide sodium or acetate) that are not identical to the FDA-approved base form [3][8][9]. Major medical organizations, including the American Diabetes Association and Obesity Medicine Association, have recommended against using non-FDA-approved compounded GLP-1s because dosing, purity, and consistency can vary significantly from batch to batch [6].

While compounded semaglutide may contain the same active ingredient base and offer lower costs or access during shortages, it carries higher risks of side effects, and the FDA has received reports of adverse reactions from its use [2][8]. For the most reliable safety and efficacy, brand-name semaglutide (such as Ozempic or Wegovy manufactured by Novo Nordisk) is the recommended choice [3][8].